viernes, 28 de julio de 2017

CFSAN Constituent Update - Release of Interagency Food Safety Analytics Collaboration (IFSAC) Wrap Up, Action Plan, and Webinar Materials

FDA Logo
Center for Food Safety and Applied Nutrition
Constituent Update

Release of Interagency Food Safety Analytics Collaboration (IFSAC) Wrap Up, Action Plan, and Webinar Materials
July 28, 2017
The Interagency Food Safety Analytics Collaboration (IFSAC) has released materials from a webinar held on May 31, 2017 about the new Strategic Plan for 2017–2021. Along with these materials, IFSAC is also issuing two other documents outlining past and future activities.
IFSAC was created in 2011 by three federal agencies—the Centers for Disease Control and Prevention (CDC), the United States Food and Drug Administration (FDA), and the Food Safety and Inspection Service (FSIS) of the United States Department of Agriculture (USDA)—to improve coordination of federal food safety analytic efforts and address cross-cutting priorities for food safety data collection, analysis, and use. Its projects and studies aim to identify foods that are important sources of human illness. IFSAC focuses analytic efforts on four priority pathogens: SalmonellaEscherichia coli (E. coli) O157:H7, Listeria monocytogenes (Lm), and Campylobacter. By bringing together data from CDC, FDA, and FSIS, and by developing sound analytical methods, IFSAC scientists can improve estimates of the sources of foodborne illness.
The webinar materials, including the presentation slides, transcript with agenda, and a link to a recording of the webinar are now available.
The “FY2012-FY2016 Wrap-Up” is an overview of IFSAC’s accomplishments from the first Strategic Plan for Foodborne Illness Source Attribution (FY2012-2016).
The “FY2017-FY2021 Action Plan” addresses the implementation of IFSAC’s new Strategic Plan (FY2017-2021). The Action Plan focuses on IFSAC’s ongoing and future projects; their alignment with the goals, strategies, and objectives of the Plan; how projects relate to each other; and tentative initiation timelines.  
For more information please visit IFSAC online, or via e-mail at IFSAC@fda.hhs.gov.

No hay comentarios: